Relationship Between Metabolic Syndrome, Alanine Aminotransferase Levels, and Liver Disease Severity in a Multiethnic North American Cohort With Chronic Hepatitis B

OBJECTIVE: Metabolic syndrome (MS) is prevalent and is associated with adverse outcomes of liver disease. We evaluated the prevalence of MS and its influence on alanine aminotransferase (ALT) levels and fibrosis, as estimated by the aspartate aminotransferase–to–platelet ratio index (APRI), in a lar...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Diabetes Care
Autors principals: Khalili, Mandana, Shuhart, Margaret C., Lombardero, Manuel, Feld, Jordan J., Kleiner, David E., Chung, Raymond T., Terrault, Norah A., Lisker-Melman, Mauricio, Sanyal, Arun, Lok, Anna S.
Format: Artigo
Idioma:Inglês
Publicat: American Diabetes Association 2018
Matèries:
Cardiovascular and Metabolic Risk
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5961397/
https://ncbi.nlm.nih.gov/pubmed/29599296
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2337/dc18-0040
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars